Molecular chaperones, amyloid-binding compounds or antioxidants?: Perspective on their application as possible therapeutic agents in reduction of cytotoxicity of amyloid oligomers
This is a temporary file and hence do not link it from a website, instead link the URL of this page if you wish to link the PDF file.
To read this article you will require Adobe© Acrobat Reader, if you do not have this installed you can download it from here
Support open access